CVS Health (CVS) earnings call transcripts

Management framed the quarter as proof that Aetna recovery and retail execution are broadening enterprise momentum, while flagging preliminary 2027 PBM pressures.

Management framed Q1 as validating Aetna’s margin recovery while preserving prudence on HSS timing, medical trends, capital deployment, and regulatory change.

Management framed 2025 as a successful reset, with Aetna recovery, pharmacy stabilization and enterprise growth initiatives intact despite Medicare rate pressure.

Management framed Q3 as continued execution, while flagging near-term PBM contract pressure and a slower Oak Street expansion path.